Search results
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 hours agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC...
FOX40 Sacramento· 2 days agoFood and Drug Administration (FDA) has granted Breakthrough Therapy designation to delpacibart etedesiran (AOC 1001), the company's lead clinical development program, for ...
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
WFRV 5 Green Bay· 1 day agoIn the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden's "Cancer Moon Shot" designed ...
Curis to Present Updated Data from the TakeAim Leukemia Study
WPRI Providence· 5 hours agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Regenex Bio eyes FDA meeting to confirm pivotal DMD trial
Clinical Trials Arena via Yahoo Finance· 1 day agoInitial strength and functional assessment data for both dose levels of the AFFINITY DUCHENNE trial...
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show...
Digital Journal· 3 hours agoORLANDO, FL / ACCESSWIRE / May 10, 2024 / RedChip Companies will air interviews with Can-Fite BioPharma Ltd. (NYSE American:CANF) and Nutriband Inc. (NASDAQ:NTRB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
Quad-City Times· 2 days agoRyan Confer Appointed Genprex President and CEO and to its Board of Directors
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
The Longview News-Journal· 2 days agoRyan Confer Appointed Genprex President and CEO and to its Board of Directors
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 17 hours agoREDWOOD CITY, Calif. & SANTA MONICA, Calif. - Kite, a Gilead Company (NASDAQ: GILD), and Arcellx,...
Regeneron gene therapy improves hearing in two children
BioPharma Dive via Yahoo Finance· 2 days agoLike Lilly’s experimental treatment, Regeneron’s medicine uses a specially engineered virus to...